Concourse Financial Group Securities, Inc. Minerva Surgical Inc Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023
BUY
$0.16 - $0.3 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.16 - $0.3 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.17 - $0.33 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.2 - $0.5 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.16 - $16.8 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.82 - $17.0 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.75 - $4.5 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$4.26 - $5.82 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$4.53 - $9.78 $0 - $0
0 New
0 $0

About MINERVA SURGICAL INC

UTRS Quotes by TradingView
  • Ticker UTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 28,860,000
  • Description
  • Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation de...
More about UTRS
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email